Value of <sup>18</sup>F-FDG PET/MRI in the Preoperative Assessment of Resectable Esophageal Squamous Cell Carcinoma: A Comparison With <sup>18</sup>F-FDG PET/CT, MRI, and Contrast-Enhanced CT.

导出 LinkOut

翻译打印收藏纠错

作者： Fei,Wang ^[1] ; Rui,Guo ^[1] ; Yan,Zhang ^[1] ; Boqi,Yu ^[1] ; Xiangxi,Meng ^[1] ; Hanjing,Kong ^[2] ; Yang,Yang ^[2] ; Zhi,Yang ^[1] ; Nan,Li ^[1]

作者单位： Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, China. ^[1] Beijing United Imaging Research Institute of Intelligent Imaging, UIH Group, Beijing, China. ^[2]

关键词 MRI PET/CT PET/MRI esophageal cancer staging

DOI 10.3389/fonc.2022.844702

PMID 35296000

发布时间 2022-03-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2022年12卷

844702页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Value of <sup>18</sup>F-FDG PET/MRI in the Preoperative Assessment of Resectable Esophageal Squamous Cell Carcinoma: A Comparison With <sup>18</sup>F-FDG PET/CT, MRI, and Contrast-Enhanced CT.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Value of <sup>18</sup>F-FDG PET/MRI in the Preoperative Assessment of Resectable Esophageal Squamous Cell Carcinoma: A Comparison With <sup>18</sup>F-FDG PET/CT, MRI, and Contrast-Enhanced CT.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除